In a Bowen Technique session, the patient lies on a bed, wearing loosely fitting clothing, and relaxes, while the therapist applies a specifically located series of gentle movements across the body. The movements are composed of a challenge to a body of   more »

The AFFIRM and SENTINEL studies showed that natalizumab was effective both as monotherapy and in combination with interferon beta (IFNbeta)-1a in patients with relapsing multiple sclerosis (MS). Further analyses of AFFIRM and SENTINEL data were conducted to determine   more »

Similarities in the onset age of progression in secondary-progressive (SP) and primary-progressive multiple sclerosis (PPMS) have been previously reported. However, with longer follow-up, more relapsing-remitting (RRMS) patients reach SPMS, such   more »

Bayer will launch a titration pack for patients with multiple sclerosis (MS) that is specially designed to make it easier for them to start Betaferon® / Betaseron (interferon beta-1b) therapy. From now on, the titration pack will be available in   more »

Taken just once a week, AVONEX is the multiple sclerosis (MS) treatment that people stay on longer. So when you're thinking about multiple sclerosis treatments, choose AVONEX. AVONEX empowers   more »

Children with MS have been shown to have a significantly increased likelihood, relative to healthy age-matched peers, of being previously infected with Epstein-Barr virus (EBV) (Alotaibi et al., 2004). EBV infection leads to persistent B-cell infection, and B-cells are known to play a role in MS. Study of children enrolled   more »